Human immunology: A case for the ascent of non-furry immunology

Immunology and Cell Biology

Volumn 89, Issue 3, 2011, Pages 330-331

  Khanna, Rajiv ^a   Burrows, Scott R ^a  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELLULAR IMMUNITY; EDITORIAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOBIOLOGY; IMMUNOLOGY; IMMUNOREGULATION; NONHUMAN;

ALLERGY AND IMMUNOLOGY; ANIMALS; HUMANS; IMMUNE SYSTEM; MODELS, ANIMAL;

EID: 79952798690     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2010.173     Document Type: Editorial

References (29)

1. Doherty PC, Zinkernagel RM. H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. J Exp Med 1975; 141: 502-507.
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol 1991; 9: 271-296.
3. Miller JF, Mitchell GF. Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med 1968; 128: 801-820.
4. Corthay A. How do regulatory T cells work? Scand J Immunol 2009; 70: 326-336.
5. Godfrey DI, McCluskey J, Rossjohn J. CD1d antigen presentation:treats for NKT cells. Nat Immunol 2005; 6: 754-756. (Pubitemid 43090459)
6. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006; 355: 1018-1028. (Pubitemid 44343545)
7. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172: 2731-2738. (Pubitemid 38263654)
8. Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N et al. Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 2009; 6: 5-9.
9. Rämer PC, Chijioke O, Meixlsperger S, Leung CS, Münz C. Micewith human immune system components as in vivo models for infections with human pathogens. Immunol Cell Biol 2011; 89: 408-416.
10. Shultz LD, Saito Y, Najima Y, Tanaka S, Ochi T, Tomizawa M et al. Generation of functional human T-cell subsetswith HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proc Natl Acad Sci USA 2010; 107: 13022-13027.
11. Yajima M, Imadome K, Nakagawa A, Watanabe S, Terashima K, Nakamura H et al. T cell-mediated control of Epstein-Barr virus infection in humanized mice. J Infect Dis 2009; 200: 1611-1615.
12. Cook MC, Vinuesa CG, Goodnow CC. ENU-mutagenesis: insight into immune function and pathology. Curr Opin Immunol 2006; 18: 627-633. (Pubitemid 44322036)
13. Papathanasiou P, Goodnow CC. Connectingmammalian genomewith phenome by ENU mouse mutagenesis: gene combinations specifying the immune system. Annu Rev Genet 2005; 39: 241-262. (Pubitemid 43011115)
14. Stranger BE, Stahl EA, Raj T. Progress and Promise of Genome-wide Association Studies for Human Complex Trait Genetics. Genetics 2010.
15. Cordaux R, Batzer MA. The impact of retrotransposons on human genome evolution. Nat Rev Genet 2009; 10: 691-703.
16. Hirschhorn JN, Lettre G. Progress in genome-wideassociation studies of human height. Horm Res 2009; 71(Suppl 2): 5-13.
17. Sagoo GS, Little J, Higgins JP. Systematic reviews of genetic association studies. Human Genome Epidemiology Network. PLoS Med 2009; 6: e28.
18. Germain RN. Vaccines and the future of human immunology. Immunity 2010; 33: 441-450.
19. Davis MM. A prescription for human immunology. Immunity 2008; 29: 835-838.
20. Khanna R, Burrows SR. Human immunology: a case for the ascent of non-furry immunology Immunol Cell Biol 2011; 89: 330-331.
21. Mortellaro A, Ricciardi-Castagnoli P. From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease. Immunol Cell Biol 2011; 89: 332-339.
22. + T-cell memory usingtheyellow fever and smallpoxvaccines. Immunol Cell Biol 2011; 89: 340-345.
23. + regulatory T cells: their knowns and unknowns. Immunol Cell Biol 2011; 89: 346-351.
24. Burrows SR, Moss DJ, Khanna R. Understanding human T-cell-mediated immuno-regulation through herpesviruses. Immunol Cell Biol 2011; 89: 352-358.
25. Horst D, Ressing ME, Wiertz EJHJ. Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls. Immunol Cell Biol 2011; 89: 359-366.
26. Wijesundara DK, Jackson RJ, Ramshaw IA, Ranasinghe C. Human immunodeficiency virus-1 vaccine design: where do we go now? Immunol Cell Biol 2011; 89: 367-374.
27. Miles JJ, Douek DC, Price DA. Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol 2011; 89: 375-387.
28. Gras S, Kjer-Nielsen L, Chen Z, Rossjohn J, McCluskey J. The structural bases of direct T-cell allorecognition: implications for T-cell-mediated transplant rejection. Immunol Cell Biol 2011; 89: 388-395.
29. Bleakley M, Riddell SR. Exploiting T cells specific for humanm in orhis to compatibility antigens for therapy of leukemia. Immunol Cell Biol 2011; 89: 396-407.